Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Non Malignant Hematologic Disorders (NMHD), Using a Chemotherapy-Only Cytoreductive Regimen and T-Cell Depleted Grafts from Alternative Donors

被引：0
|
作者：
Boulad, Farid [1 ]
Kernan, Nancy A. [1 ]
Prockop, Susan E. [1 ]
Scaradavou, Andromachi [1 ]
Lehrman, Rachel [1 ]
Ruggiero, Julianne M. [1 ]
Curran, Kevin [1 ]
Kobos, Rachel [1 ]
O'Reilly, Richard [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, Bone Marrow Transplant Serv, New York, NY 10021 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2013.12.269
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
241
引用
收藏
页码：S167 / S167
页数：1
相关论文
共 50 条
  • [1] Chemotherapy-Only Preparative Regimen for T-Cell Depleted Hematopoietic Stem Cell Transplantation of Patients with Fanconi Anemia From Alternative Donors
    Boulad, Farid
    Davies, Stella M.
    Williams, David A.
    Margolis, David A.
    Klein, Elizabeth G.
    Lehmann, Leslie E.
    Duncan, Christine
    Guinan, Eva C.
    Mehta, Parinda A.
    BLOOD, 2012, 120 (21)
  • [2] Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or -mismatched donors
    Mussetti, Alberto
    Kernan, Nancy A.
    Prockop, Susan E.
    Scaradavou, Andromachi
    Lehrman, Rachel
    Ruggiero, Julianne M.
    Curran, Kevin
    Kobos, Rachel
    O'Reilly, Richard
    Boulad, Farid
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2016, 33 (06) : 347 - 358
  • [3] Hematopoietic stem cell transplantation for the treatment of Fanconi anemia using a fludarabine-based cytoreductive regimen and T-cell depleted grafts from alternative donors
    Boulad, F
    Auerbach, AD
    Kolb, A
    Small, TN
    Prasad, V
    Prockop, S
    Torok-Castanza, J
    Casson, A
    Collins, NH
    Kernan, NA
    O'Reilly, RJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 39 - 40
  • [4] Complications after T-CELL depleted allogeneic hematopoietic stem cell transplantation (HSCT).
    Bieri, S
    Roosnek, E
    Helg, C
    Ozsahin, H
    Wacker, P
    Chapuis, B
    Miralbell, R
    Chalandon, Y
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 141 - 141
  • [5] CHEMOTHERAPY-ONLY PREPARATIVE REGIMEN FOR ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH FANCONI ANEMIA
    Mehta, P. A.
    Davies, S. M.
    Duncan, C.
    Guinan, E.
    Klein, E.
    Edwards, S.
    Lehmann, L.
    Margolis, D.
    Williams, D.
    Boulad, F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S301 - S302
  • [6] A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies
    Spitzer, Barbara
    Jakubowski, A.
    Papadopoulos, Esperanza B.
    Fuller, Kirsten
    Hilden, Patrick D.
    Young, James W.
    Barker, Juliet N.
    Koehne, Guenther
    Perales, Miguel-Angel
    Hsu, Katharine C.
    van den Brink, Marcel R.
    Kernan, Nancy A.
    Prockop, Susan E.
    Scaradavou, Andromachi
    Castro-Malaspina, Hugo
    O'Reilly, Richard J.
    Boulad, Farid
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (12) : 2088 - 2095
  • [7] Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted (TCD) hematopoietic stem cell transplants (HSCT) for the treatment of myeloid malignancies
    Boulad, Farid
    Jakubowski, Ann
    Papadopoulos, Esperanza
    Hsu, Katharine C.
    Perales, Miguel Angel
    van den Brink, Marcel
    Young, James W.
    Chiu, Michelle
    Keman, Nancy A.
    Prockop, Susan E.
    Scaradavou, Andromachi
    Small, Trudy N.
    Castro-Malaspina, Hugo
    O'Reilly, Richard J.
    BLOOD, 2007, 110 (11) : 878A - 878A
  • [8] Allogeneic hematopoietic stem cell transplantation from matched related and unrelated donors in children with hematologic malignancies using "naive" (CD45RA+) t-cell-depleted grafts
    Molina Angulo, B.
    Lopez Torija, I.
    Gonzalez Vicent, M.
    Zubicaray Salegui, J.
    Sevilla Navarro, J.
    Sebastian Perez, E.
    Iriondo Alzola, J.
    Vinagre Enriquez, S.
    Diaz Perez, M. A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 366 - 367
  • [9] Stem cell transplantation (SCT) for the treatment of Fanconi anemia (FA) using a fludarabine (Flu) based cytoreductive regimen and T-cell depleted grafts from unrelated or mismatched related donors.
    Boulad, F
    Auerbach, AD
    Small, TN
    Prasad, V
    Torok-Castanza, J
    Casson, A
    Duschock, B
    Collins, N
    Kernan, NA
    O'Reilly, RJ
    BLOOD, 2002, 100 (11) : 858A - 858A
  • [10] Radiation-free cytoreductive regimens and T-cell depleted allogeneic stem cell transplants (HSCT) for the treatment of 65 pediatric patients with hematologic malignancies
    Boulad, F.
    Kernan, N. A.
    Prockop, S. E.
    Kobos, R.
    Judge, A.
    Cancio, M.
    Curran, K. J.
    Jackson, C. C.
    Spitzer, B.
    Koehne, G.
    O'Reilly, R. J.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S334 - S334
12345